A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
Built for More: Uniform Coverage, Higher Yields, and Confident Variant Characterization.
bDanish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark cDepartment of Neurology and Center of Clinical Neuroscience, First Faculty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results